Net (Loss) Income Attributable to Shareholders of Crawford & Company per Common Share

The Company computes earnings per share of its non-voting Class A Common Stock ("CRD-A") and voting Class B Common Stock ("CRD-B") using the two-class method, which allocates the undistributed (loss) earnings in each period to each class on a proportionate basis. The Company's Board of Directors has the right, but not the obligation, to declare higher dividends on the CRD-A shares than on the CRD-B shares, subject to certain limitations. In periods when the dividend is the same for CRD-A and CRD-B or when no dividends are declared or paid to either class, the two-class method generally will yield the same (loss) earnings per share for CRD-A and CRD-B. During the first quarter of 2020 and 2019, the Board of Directors declared a higher dividend on CRD-A than on CRD-B.

The computations of basic net (loss) income attributable to shareholders of Crawford & Company per common share were as follows:



	Three Months Ended
	March 31, 2020						March 31, 2019
(in thousands, except per share amounts)	CRD-A			CRD-B			CRD-A		CRD-B
(Loss) earnings per share - basic:
Numerator:
Allocation of undistributed (loss) earnings	$	(8,436	)	$	(6,232	)	$	1,604	$	1,223
Dividends paid	2,140			1,129			2,131		1,151
Net (loss) income attributable to common shareholders, basic	$	(6,296	)	$	(5,103	)	$	3,735	$	2,374

Denominator:
Weighted-average common shares outstanding, basic	30,562			22,578			30,658		23,367
(Loss) earnings per share - basic	$	(0.21	)	$	(0.23	)	$	0.12	$	0.10

The computations of diluted net (loss) income attributable to shareholders of Crawford & Company per common share were as follows:



	Three Months Ended
	March 31, 2020						March 31, 2019
(in thousands, except per share amounts)	CRD-A			CRD-B			CRD-A		CRD-B
(Loss) earnings per share - diluted:
Numerator:
Allocation of undistributed (loss) earnings	$	(8,436	)	$	(6,232	)	$	1,614	$	1,213
Dividends paid	2,140			1,129			2,131		1,151
Net (loss) income attributable to common shareholders, diluted	$	(6,296	)	$	(5,103	)	$	3,745	$	2,364

Denominator:
Weighted-average common shares outstanding, basic	30,562			22,578			30,658		23,367
Weighted-average effect of dilutive securities	—			—			448		—
Weighted-average common shares outstanding, diluted	30,562			22,578			31,106		23,367
(Loss) earnings per share - diluted	$	(0.21	)	$	(0.23	)	$	0.12	$	0.10

Listed below are the shares excluded from the denominator in the preceding computation of diluted (loss) earnings per share for CRD-A because their inclusion would have been antidilutive:



	Three Months Ended
(in thousands)	March 31, 2020	March 31, 2019
Shares underlying stock options excluded	1,904	931
Performance stock grants excluded because performance conditions have not been met ⁽¹⁾	932	1,144


⁽¹⁾	Compensation cost is recognized for these performance stock grants based on expected achievement rates; however, no consideration is given to these performance stock grants when calculating diluted earnings per share until the performance measurements have been achieved.

The following table details shares issued during the three months ended March 31, 2020 and March 31, 2019. These shares are included from their dates of issuance in the weighted-average common shares used to compute basic and diluted (loss) earnings per share for CRD-A in the table above. There were no shares of CRD-B issued during any of these periods.



	Three Months Ended
(in thousands)	March 31, 2020	March 31, 2019
CRD-A issued under Non-Employee Director Stock Plan	81	76
CRD-A issued under the U.K. ShareSave Scheme	1	9
CRD-A issued under Executive Stock Bonus Plan	—	30

The Company's share repurchase authorization, approved in July 2017 (the "2017 Repurchase Authorization"), provided the Company with the ability to repurchase up to 2,000,000 shares of CRD-A or CRD-B (or both). The 2017 Repurchase Authorization was terminated on May 8, 2019.

Effective May 9, 2019, the Company's Board of Directors authorized the repurchase of up to 2,000,000 shares of CRD-A or CRD-B (or a combination of the two) through December 31, 2020 (the "2019 Repurchase Authorization"). Under the 2019 Repurchase Authorization, repurchases may be made for cash, in the open market or privately negotiated transactions at such times and for such prices as management deems appropriate, subject to applicable contractual and regulatory restrictions. At March 31, 2020, the Company had remaining authorization to repurchase 642,097 shares under the 2019 Repurchase Authorization.

During the three months ended March 31, 2020, the Company repurchased 155,351 shares of CRD-A and 161,459 shares of CRD-B at an average cost of $8.42 for each share. During the three months ended March 31, 2019, the Company repurchased 421,427 shares of CRD-A and 1,376,889 shares of CRD-B at an average cost of $9.13 for each share. All shares repurchased during the three months ended March 31, 2019 were purchased pursuant to a stock purchase agreement authorized by the Board of Directors separate from the 2017 Repurchase Authorization and the 2019 Repurchase Authorization.